Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Lyon

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Oncology Nursing Forum|February 18, 2021
Positive Yet Unequal TrendsDeborah Lyon
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 5, 2018
Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up SamplesDeborah Lyon, Natasha Lapteva, Adrian P Gee
Research Square|April 22, 2024
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancersDavid Steffin, Nisha Ghatwai, Antonino Montalbano, et al.
Nature|November 28, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancersDavid Steffin, Nisha Ghatwai, Antonino Montalbano, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Oncology Nursing Forum|February 18, 2021
Positive Yet Unequal TrendsDeborah Lyon
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 5, 2018
Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up SamplesDeborah Lyon, Natasha Lapteva, Adrian P Gee
Research Square|April 22, 2024
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancersDavid Steffin, Nisha Ghatwai, Antonino Montalbano, et al.
Nature|November 28, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancersDavid Steffin, Nisha Ghatwai, Antonino Montalbano, et al.
Pageof 1